# Nuclide record relative-biological-effectiveness (term). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/terms/relative-biological-effectiveness/>
  a schema:DefinedTerm ;
  nuclide:kind "term" ;
  schema:identifier "relative-biological-effectiveness" ;
  schema:name "Relative biological effectiveness (RBE)"@en ;
  schema:description "A number that says how much more (or less) biological damage a given amount of one type of radiation causes compared with the same physical amount of a reference radiation. Alpha particles are typically several times more damaging, gray for gray, than the beta particles used in more established radioligand therapies."@en ;
  schema:url <https://nuclide.cc/terms/relative-biological-effectiveness/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pmc.ncbi.nlm.nih.gov/articles/PMC3984880/>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC10495309/> ;
  nuclide:related <https://nuclide.cc/terms/linear-energy-transfer/>, <https://nuclide.cc/terms/equivalent-dose/>, <https://nuclide.cc/terms/alpha-vs-beta/>, <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/ac-225/> ;
  nuclide:technologies <https://nuclide.cc/technologies/targeted-alpha-therapy/>, <https://nuclide.cc/technologies/radioligand-therapy/> .